Vitamin D Receptor (VDR) gene polymorphism and risk of ischemic stroke
© Prabhakar et al; licensee BioMed Central Ltd. 2014
Published: 21 January 2014
Vitamin D deficiency is associated with various chronic disease conditions. The expression and nuclear activation of vitamin D receptor (VDR) are essential for the effect of Vitamin D, because vitamin D is involved in various signaling cascades. Few polymorphisms in VDR gene have been reported to be associated with cardiovascular disease and hypertension. We sought to examine the association between VDR gene variants and risk of ischemic stroke in Indian population.
We recruited 250 patients diagnosed with ischemic stroke and 300 age and gender-matched healthy control subjects, after informed consent. 4 SNPs in VDR gene (ApaI, BsmI, FokI & TaqI), were genotyped by using PCR-RFLP method. Serum Vitamin D levels were determined by ELISA. The association of each SNP with the risk of stroke was analyzed by multiple logistic regressions by adjusting with age, gender, smoking, alcohol, hypertension and diabetes.
The VDR BsmI bb and FokI Ff genotypes were associated with increased risk for ischemic stroke (OR: 1.76; 95% CI; 1.01 – 3.08; P = 0.04) & (OR: 1.52; 95% CI; 0.99 – 2.31; P = 0.05) respectively. No association was observed between TaqI and ApaI polymorphisms and ischemic stroke. Vitamin D deficient (<20ng/ml) subjects with Bsm I Bb & bb genotypes had significantly higher risk for ischemic stroke (OR: 2.24; 95% CI; 1.11 – 4.56; P = 0.03) & (OR: 2.27; 95% CI; 1.05 – 4.99; P = 0.034), respectively. Similarly, increased risk for stroke was observed in Vitamin D deficient subjects with TaqI Tt genotype (OR: 2.77; 95% CI; 1.45 – 5.31; P = 0.002), and ApaI Aa genotype (OR: 2.456; 95% CI; 1.25 – 4.81; P = 0.009).
In this first study to elucidate the role of VDR gene polymorphism in ischemic stroke patients, we found that genetic variants in VDR gene was associated with an increased risk for stroke especially in Vitamin D deficient subjects. Our findings could contribute to the development of strategies for the prevention of ischemic stroke.
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.